Cosmetics Regulatory

Cosmetic Label Compliance

Ensure your cosmetic product labels meet all CDSCO and Cosmetics Rules 2020 requirements — from ingredient listing and warnings to label format review.

Service Overview

Cosmetic label compliance in India is governed by Schedule Q of the Cosmetics Rules 2020. All cosmetic products sold in India — domestic or imported — must display specific mandatory information on their labels in a prescribed format.

Schedule Q mandates the declaration of: product name and function, complete list of ingredients (INCI names in descending order), net content, batch number, manufacturing date and best before date, manufacturer and importer details, country of origin, and any required warnings or usage instructions.

Non-compliant labels are a common reason for CDSCO import license rejections and can result in product seizure at ports. MedRegX India provides comprehensive cosmetic label review and compliance services to ensure your labels meet all Indian regulatory requirements before market entry.

Complete Schedule Q compliance review
INCI name verification against approved lists
Mandatory warning identification
Label format and font size compliance
Multi-language label strategy
Stickering and overprinting guidance for imports
Label review before registration application
Digital label management support

Key Takeaways

  • Labelling is legally enforceable, not cosmetic — a non-compliant label can block registration and hold a consignment at customs.
  • Cosmetic labels follow Schedule Q; packaged food labels follow FSSAI rules; each product type has its own mandatory declarations.
  • Mandatory elements typically include ingredients, manufacturer/importer details, batch and manufacturing data, shelf life and warnings.
  • Imported goods almost always need over-labelling or re-labelling to add India-specific declarations before sale.
  • A pre-print label review is far cheaper than reprinting packaging or clearing a detained shipment.

Why Labels Detain More Shipments Than Formulations

Companies expect the hard part of market entry to be the product itself, but in practice a large share of consignments are held for labelling defects — issues that are entirely avoidable and cheap to fix on paper, yet expensive to fix once packaging is printed or goods are at the port. A label is a legal document: it must carry specific declarations, in a defined form, and any omission or error gives an inspector or customs officer grounds to hold the goods. For cosmetics this means Schedule Q; for packaged foods it means the FSSAI labelling regulations; for other regulated products it means their own rules. Each has its own list of mandatory elements, and each is enforced.

The problem is sharpest for imports. A product arriving with only its home-market label is missing the India-specific declarations — importer details, the registration or licence number, ingredient disclosure in the required form, and mandatory warnings — and cannot be sold as-is. We identify exactly what is missing and advise on compliant over-labelling or re-labelling, so a first shipment clears instead of sitting in a bonded warehouse while the problem is sorted out.

  • Ingredient / composition disclosure in the prescribed format.
  • Manufacturer and importer name and address.
  • Batch number, manufacturing details and shelf life / expiry.
  • Mandatory warnings, symbols and the registration/licence number.

A Pre-Print Review That Pays for Itself

The cheapest moment to fix a label is before it is printed. Our label-compliance review checks artwork against the exact rules that apply to the product — placement, wording, font-size minimums, mandatory symbols and declarations — and returns a marked-up report of everything that must change, with the specific rule behind each point. Done before a print run, it costs a fraction of reprinting thousands of units, and a fraction of the cost of a detained consignment.

The review also feeds directly into registration. CDSCO and FSSAI both scrutinise labelling as part of the application, so a label that has already been vetted removes a common source of queries and rejections. For brands managing many SKUs, we work through the whole range consistently, so the same declarations, formats and warnings are applied correctly across every product rather than fixed one crisis at a time.

Required Documentation

Current product label artwork
Complete ingredient formulation
Product category and intended use information
Country of origin details
Importer information

"Accurate documentation is 70% of the battle. Our experts pre-audit every file before submission."

Our Delivery Workflow

01

Label Review

Review current label artwork against all Schedule Q mandatory requirements and identify compliance gaps.

02

INCI Verification

Verify all ingredient INCI names, concentrations, and order of listing for regulatory accuracy.

03

Label Redesign Guidance

Provide specific recommendations for label modifications to achieve full Schedule Q compliance.

04

Compliance Sign-off

Issue a label compliance review report confirming readiness for CDSCO registration and market entry.

FAQ

Frequently Asked Questions

Have questions? Find direct, humanized answers about the regulatory approvals and timelines.

Under Schedule IX of the Cosmetics Rules 2020, cosmetic labels must include: COS-2 registration number, full ingredient list in descending order (INCI nomenclature), batch number, manufacturing and expiry dates, country of origin, net quantity, and the name and address of the Authorized Indian Importer.
INCI (International Nomenclature of Cosmetic Ingredients) is the standard naming system required for listing ingredients on cosmetic labels. India follows IS 4707 which mandates INCI names. Proprietary or trade names for ingredients are not acceptable on labels submitted to CDSCO.
Yes, CDSCO permits the use of a sticker or overprint on imported cosmetic packages to add mandatory Indian labeling information, provided the sticker does not obscure or conflict with the original label and is applied before customs clearance.
Any claim suggesting medicinal or therapeutic benefits is prohibited on cosmetic labels. Terms like "heals," "cures," "treats," or disease-related claims cross into drug territory under the Drugs & Cosmetics Act and can lead to product seizure and prosecution.

Launch Your Product In Record Time

Red tape shouldn't decide your launch date. We keep the paperwork moving and the queries answered, so approvals come through sooner.

Start My Application
Compliant With 2024 Amendments